Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2021 Jun 5;189(1):145–154. doi: 10.1007/s10549-021-06284-7

Figure 2.

Figure 2.

Proportion of study participants who achieved a weight loss ≥5% (left panel) or ≥10% (right panel) of baseline body weight at week 52 by randomized group

Note: Unobserved data were multiply imputed using a parametric logistic regression imputation method and analyzed using generalized linear model that was adjusted for randomization stratification factors including age, receipt of radiotherapy, number of lymph nodes resected, lymphedema severity, and body mass index. ETD, Estimated Treatment Difference; CI, Confidence Interval.